Extended Duration Bridge to Orthotopic Heart Transplant Utilizing the Impella RP Flex-Reference-Cited by-同舟云学术

Extended Duration Bridge to Orthotopic Heart Transplant Utilizing the Impella RP Flex

Published:2024-05-03 Issue: Volume: Page:
ISSN:1058-2916
Container-title:ASAIO Journal
language:en
Short-container-title:

Author:

Maigrot Jean-Luc A.¹^ORCID,Lee Ran²,Higgins Andrew²,Mountis Maria²,Unai Shinya¹,Weiss Aaron J.¹

Affiliation:

1. From the Department of Thoracic and Cardiovascular Surgery, Kaufman Center for Heart Failure Treatment and Recovery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio

2. Department of Cardiovascular Medicine, Kaufman Center for Heart Failure Treatment and Recovery, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.

Abstract

We present a case of a 56 year old man presenting with cardiogenic shock from isolated right ventricular failure due to arrhythmogenic right ventricular cardiomyopathy who was successfully bridged to heart transplantation after 29 days on an Impella RP Flex right ventricular assist device. This represents the longest reported duration of support with the device to date and highlights the utility of this platform in the management of severe right ventricular failure.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarction.;Josiassen;Eur Heart J Acute Cardiovasc Care,2021

2. Impella RP for treatment of right ventricular shock: Appropriate unloading never gets old.;Goldstein;Catheter Cardiovasc Interv,2020

3. Impella RP Flex with SmartAssist receives FDA pre-market approval.;Han;Artif Organs,2023

4. Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device.;Anderson;J Heart Lung Transplant,2015

5. Impella RP for patients with acute right ventricular failure and cardiogenic shock: A subanalysis from the IMP-IT Registry.;Botti;J Pers Med,2022